1. Home
  2. AVBP vs CPF Comparison

AVBP vs CPF Comparison

Compare AVBP & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • CPF
  • Stock Information
  • Founded
  • AVBP 2021
  • CPF 1954
  • Country
  • AVBP United States
  • CPF United States
  • Employees
  • AVBP N/A
  • CPF N/A
  • Industry
  • AVBP
  • CPF Major Banks
  • Sector
  • AVBP
  • CPF Finance
  • Exchange
  • AVBP NYSE
  • CPF Nasdaq
  • Market Cap
  • AVBP 862.8M
  • CPF 725.7M
  • IPO Year
  • AVBP 2024
  • CPF N/A
  • Fundamental
  • Price
  • AVBP $18.66
  • CPF $26.16
  • Analyst Decision
  • AVBP Strong Buy
  • CPF Buy
  • Analyst Count
  • AVBP 8
  • CPF 1
  • Target Price
  • AVBP $38.38
  • CPF $30.00
  • AVG Volume (30 Days)
  • AVBP 239.9K
  • CPF 130.7K
  • Earning Date
  • AVBP 08-13-2025
  • CPF 07-25-2025
  • Dividend Yield
  • AVBP N/A
  • CPF 4.05%
  • EPS Growth
  • AVBP N/A
  • CPF 6.71
  • EPS
  • AVBP N/A
  • CPF 2.24
  • Revenue
  • AVBP N/A
  • CPF $253,722,000.00
  • Revenue This Year
  • AVBP N/A
  • CPF $0.80
  • Revenue Next Year
  • AVBP N/A
  • CPF $6.33
  • P/E Ratio
  • AVBP N/A
  • CPF $11.68
  • Revenue Growth
  • AVBP N/A
  • CPF 6.59
  • 52 Week Low
  • AVBP $15.47
  • CPF $23.16
  • 52 Week High
  • AVBP $36.37
  • CPF $33.25
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 29.95
  • CPF 31.04
  • Support Level
  • AVBP $21.10
  • CPF $27.05
  • Resistance Level
  • AVBP $22.29
  • CPF $28.17
  • Average True Range (ATR)
  • AVBP 1.02
  • CPF 0.65
  • MACD
  • AVBP -0.29
  • CPF -0.32
  • Stochastic Oscillator
  • AVBP 2.38
  • CPF 14.46

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.

Share on Social Networks: